← Evidence map

ArticleKidney international reports2025

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy.

Hiddo J L Heerspink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39810771